Fundraising FoxAphelion Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery.
BiotechHealthtechMedical DevicesDenver, US
H David Humes(Director)Eric Schlorff(Executive Officer, Director)inPeter DeComo(Director)Mark Morsfield(Executive Officer)inR James Danehy(Executive Officer, Director)Jen Baird, NACD.DCin
Co-investorsCapital Midwest FundEarly Stage Partners, LPWMU Biosciences Research & Commercialization Center
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)in
BoardJosh Baltzell(Director)inJan Garfinkle(Director)in
Co-investorsArboretum VenturesScientific Health DevelopmentZühlke VenturesAsahi Kasei Corporate VenturesCadence Healthcare VenturesOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.